Pidilite Q2 Results: Sales Jump 21%, But Profit Growth Slows

Pidilite Industries, the company behind popular brands like Fevicol, Dr. Fixit, M-Seal and Fevikwik, reported strong revenue growth in Q2 FY27. Consolidated net sales increased 21.1% year-on-year to ₹4,285 crore, supported by healthy demand across its businesses. However, the company's profitability tells a different story.

Despite the strong sales growth, Pidilite's EBITDA increased by just 3.1%, while net profit grew 7.1%. A sharp rise in raw material costs put pressure on profitability, resulting in a significant decline in operating margins.

This raises an important question for investors. If Pidilite is selling more products, why isn't it making proportionately higher profits? And more importantly, is this temporary cost pressure or something that could affect the company's profitability in the coming quarters?

Pidilite Q2 FY27 Results: Revenue vs Profit Growth

Pidilite's consolidated financial performance shows a clear difference between revenue growth and profit growth.

The biggest concern is the difference between revenue and EBITDA growth. While Pidilite generated ₹745 crore in additional quarterly sales, its EBITDA increased by only ₹27 crore.

The operating margin also declined from 24% to 20.5%, a contraction of 350 basis points. This means Pidilite earned considerably less operating profit from every ₹100 of sales compared with the same quarter last year.

However, the slowdown does not appear to be driven by weak demand. The company's underlying volume growth remained healthy, suggesting that rising costs were the bigger challenge.

Why Did Pidilite's Profit Growth Slow Despite Strong Sales?

The main reason behind Pidilite's slower profit growth was the sharp increase in material costs.

1. Raw Material Costs Grew Much Faster Than Revenue

Pidilite's consolidated material costs increased 38.3% year-on-year, considerably faster than its 21.1% sales growth.

The difference becomes clearer when we examine how much of the company's revenue was consumed by material expenses.

In Q2 FY26, Pidilite spent approximately ₹45 on materials for every ₹100 of net sales. In Q2 FY27, that increased to nearly ₹52.

This is a significant change for a company whose profitability depends partly on managing input costs efficiently.

Pidilite manufactures adhesives, sealants, waterproofing solutions and other specialty chemical products. Its production costs are influenced by chemical raw materials, including derivatives linked to global petrochemical markets.

When input costs rise faster than selling prices, companies face pressure on their profit margins.

Pidilite's latest results suggest that its higher sales and pricing actions were not enough to fully offset this cost inflation during the quarter.

2. Lower Advertising Expenses Helped, But Could Not Protect Margins

Interestingly, not all of Pidilite's expenses increased sharply.

Consolidated advertising and sales promotion expenses declined from ₹150 crore to ₹132 crore, a reduction of 11.8% year-on-year.

Staff costs grew 8.6%, while other expenses increased 16.7%. Both grew more slowly than revenue.

This suggests that Pidilite maintained reasonable control over several operating expenses. However, these savings were insufficient to compensate for the sharp increase in material costs.

For investors, this distinction matters. The company is not experiencing a broad-based rise in every operating expense. Instead, material cost inflation appears to be the primary factor affecting operating profitability.

Is Pidilite's Growth Still Strong? What Volume Numbers Reveal

Although profitability came under pressure, Pidilite's underlying business continued to grow.

On a standalone basis, net sales increased 21.7% year-on-year to ₹3,982 crore. More importantly, underlying volume growth stood at 10.7%.

Underlying volume growth measures the growth in the quantity of products sold, helping investors separate demand growth from the impact of prices and product mix.

Pidilite's two major business segments also reported healthy growth.

The Consumer and Bazaar business includes products sold to consumers, retailers and professionals. It is an important part of Pidilite's operations, supported by established brands such as Fevicol and Dr. Fixit.

Its 11.1% underlying volume growth suggests that demand remained healthy even as the company faced higher input costs.

Similarly, the B2B segment recorded 9.2% volume growth, indicating continued demand from industrial and business customers.

The important takeaway is that Pidilite's profit slowdown was not accompanied by a slowdown in volumes. This creates the possibility of stronger profitability if input costs stabilise, although margin recovery is not guaranteed.

Pidilite's Consumer and B2B Businesses: Sales Grow, But Segment Profits Struggle

A closer look at segment profitability reveals another concern. Pidilite's Consumer and Bazaar business reported 20.7% revenue growth, but its profit before interest and tax, or PBIT, increased only 2.5%.

The situation was weaker in the B2B segment, where revenue grew 21.8%, but PBIT declined 3.4%.

This shows that the pressure on profitability was not limited to one part of the business.

Both segments generated strong revenue growth, but neither delivered a comparable improvement in operating profits.

The B2B business is particularly worth monitoring because its segment profit declined despite sales growth.

For investors, the key question is whether future revenue growth can translate into stronger segment profitability once input cost pressures ease.

What Should Pidilite Investors Watch Next?

Pidilite's Q2 results highlight three important areas that could influence its profitability in the coming quarters.

Raw material costs and operating margins: Material expenses consumed a significantly larger share of sales during Q2. Investors should monitor whether this ratio begins to decline and whether EBITDA margins recover from 20.5%.

Volume growth and pricing power: Pidilite delivered 10.7% standalone underlying volume growth despite cost pressures. Maintaining healthy volumes while improving selling prices would be important for future profitability.

Profitability across business segments: Both Consumer and Bazaar and B2B reported strong revenue growth but weaker profit performance. A sustained recovery would require better profit conversion across these businesses, not just higher sales.

Author's Take

Pidilite's Q2 FY27 results present an interesting situation. The company's underlying business continues to grow at a healthy pace, supported by double-digit volume growth across its major segments. However, that growth is not translating into equally strong profitability.

The most significant concern is the sharp rise in material costs, which pushed consolidated EBITDA margins down by 350 basis points. Even though Pidilite controlled several other expenses, it could not fully protect its margins.

The encouraging part is that customer demand remains healthy. This suggests that the immediate challenge is managing costs and protecting profitability rather than reviving sales.

For investors, the next few quarters will be important in understanding whether Pidilite can restore its margins while maintaining strong volume growth.

Ultimately, the bigger question is no longer whether Pidilite can grow its sales. It is how much of that growth the company can convert into profits.